Evidence map›Paper›PMID 29057227›Full record

ReviewFrontiers in cardiovascular medicine2017

Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells.

Francesco Angelini, Francesca Pagano, Antonella Bordin, Vittorio Picchio, Elena De Falco, Isotta Chimenti

Abstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Research progress on blood therapy for anti-aging.Journal of advanced research · 2026
    Review
  3. Article
  4. Article
  5. Recent Advances in 3D Cultures.International journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Aging and the Krüppel-like factors.Trends in cell & molecular biology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francesco AngeliniDepartment of Medical Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Latina, Italy.
Francesca PaganoDepartment of Medical Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Latina, Italy.
Antonella BordinDepartment of Medical Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Latina, Italy.
Vittorio PicchioDepartment of Medical Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Latina, Italy.
Elena De FalcoDepartment of Medical Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Latina, Italy.
Isotta ChimentiDepartment of Medical Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Latina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global aging is a hallmark of our century. The natural multifactorial process resulting in aging involves structural and functional changes, affecting molecules, cells, and tissues. As the western population is getting older, we are witnessing an increase in the burden of cardiovascular events, some of which are known to be directly linked to cellular senescence and dysfunction. In this review, we will focus on the description of a few circulating molecules, which have been correlated to life span, aging, and cardiovascular homeostasis. We will review the current literature concerning the circulating levels and related signaling pathways of selected proteins (insulin-like growth factor 1, growth and differentiation factor-11, and PAI-1) and microRNAs of interest (miR-34a, miR-146a, miR-21), whose bloodstream levels have been associated to aging in different organisms. In particular, we will also discuss their potential role in the biology and senescence of cardiovascular regenerative cell types, such as endothelial progenitor cells, mesenchymal stromal cells, and cardiac progenitor cells.

Indexed as

cardiac cell therapycardiac progenitor cellscardiovascular regenerationcell senescenceendothelial progenitor cellsinsulin-like growth factor 1

Identifiers

PMID29057227
PMCPMC5635266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.